Carpe Diem
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Somebody just dumped their shares.
Go NYMX!!! GLTA!
I think he is going to just keep buying. This price is a steal.
This dudes got an endless supply of cash.
looking into the insider buying at Nymox Pharmaceutical Corporation (NASDAQ:NYMX), which has seen one Board member buy regularly over the past several months. Director James G. Robinson purchased 39,500 shares last week at prices that ranged from $2.19 to $2.53 per share. Mr. Robinson, who was appointed to the company’s Board in July 2015, currently owns 2.76 million shares directly, as well as holding an additional indirect ownership stake of 45,050 shares.
Nymox Pharmaceutical is a biopharmaceutical company that focuses on the development of a drug candidate, called NX-1207, for the treatment of benign prostatic hyperplasia or BPH and the treatment of low-grade localized prostate cancer. Moreover, the company also markets NicAlert and TobacAlert, inexpensive tests that use urine or saliva to detect whether an individual uses tobacco products (NicAlert) or has been recently exposed to second-hand smoke (TobacAlert). Going back to the NX-1207 drug candidate, the company announced promising initial clinical results from a Phase 3 development program in BPH last summer, so the company’s management intends to meet with regulatory authorities across the globe to discuss the possibility of filing for approval. Nonetheless, investors should be aware that the company’s NX-1207 enlarged prostate treatment will face strong competition from existing products should the drug receive approval. It is said that nine drugs have been approved for the treatment of BPH, which include five proprietary drugs and four generics. In early February, Nymox Pharmaceutical raised $2.1 million through a private placement at $2.00 per share with no warrants, with the raised capital being expected to be used for the continuation of the company’s projects.
Shares of Nymox Pharmaceutical have advanced by 135% in the past 52 weeks, but are down by 28% year-to-date. No money managers tracked by Insider Monkey had long positions in Nymox Pharmaceutical Corporation (NASDAQ:NYMX) at the end of December.
Great job! I had an average of $3.44 but was able to pick up another 2,000 shares at $2.03 and now I'm averaging low $3 range.
2016 will be NYMX's big year. Buy and hold my friends!
We will be back over $3 by the end of this week.
Picked up another 1,000 shares at $2.03
Got some financing news. Looks like they will be able to move forward now.
Did anyone else just see that spike???
EMBR looking good!
Hopefully the bloodbath is over and this turns around this week.
Let's close above $3.00. I can't believe it dropped below 3 with all of the insured buying.
He is really down on his investment. You would think he'd put in some more to average down.
Robinson! Where are you? We need some more buying.
I would have like to have seen 10 on the close but at lease we got the 9 back.
Thanks for the info. I'll be patient.
I can't believe I am now investing in Pot.
Here we go. Back down to 7s. This sucks.
I guess you have to start taking these strips for all of this to start making sense.
I guess you have to start taking some of the strips for this all to start making sense.
Oh my! 0.022! It's flying..... LOL
Maybe Edward Moser, or Edward Lane Moser is really Keyser Soze.
James George Robinson, a director of Nymox Pharmaceutical Corporation, recently acquired 25,000 shares of the company. The buys took place at prices ranging from $3.38 to $3.79 per share, on dates ranging from December 28 to December 30, 2015. Robinson now owns 2,677,700 shares of the company. Robinson operates out of Baltimore, MD.
That dude is out of control.
GLTU, GLTA NYMX shareholders. This is going to fly......soon!
Wouldn't he have done that when he bought over the summer and it ran up over 4 a few times. Also, he is buying some of it in a trust. I think this is a very obvious bullish sign. I don't see this as a day trade or short term move. This guy is on the inside and knows there is a big company change going on.
Robinson is buying even more shares!!!!!!!
Wake up people and buy this stock!
News! This is going to fly today!!!,!
Went as high as $4.49 in after hours trading. Let's see what pre market does tomorrow morning.
GOOOOOOOO NYMX!!!!!
The meeting starts at 4:30
Today is Meeting Day!
I just put in an order to buy 3mil at 12.
Well said.
Just picked up 2mil more shares at 11. Lets Go WOFA!!!!
I'm showing two trades. One for 14 mil and the other for 9 mil and change.
Nice pre market trades!
What the f was that trade? 9 mil at .00192
Could be waking back up again